Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease.

Neurobiology of aging - 1 Jan 2000

Wakabayashi K, Narisawa-Saito M, Iwakura Y, Arai T, Ikeda K, Takahashi H, Nawa H

Abstract excerpt

Glutamate receptors play crucial roles in cognition and memory. We have quantitated the protein levels of alpha-amino-isoxazolepropionic acid (AMPA)-type (GluR1) and N-methyl-D-aspartate-type (NMDAR1) glutamate receptors in postmortem brain tissues of patients with Alzheimer's disease and age-matched controls using western blotting. The bolts carrying fully denatured proteins were probed with antibodies specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Specificity
Share to Brain Chemistry
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Entorhinal Cortex

Share to Hippocampus

Share to Receptors, AMPA

Share to Receptors, N-Methyl-D-Aspartate

Share to Synapses

Source

Identifiers

PMID: 10588576
DOI: 10.1016/s0197-4580(99)00035-4

Genes

PSD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease.PMID 10588576Read ↗

Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer's diseaseSemantic proximity Read ↗

Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.Semantic proximity Read ↗

GlutamateNMDA receptor NR1 subunit mRNA expression in Alzheimer's diseaseSemantic proximity Read ↗

Reduced Expression of the Inhibitory Synapse Scaffolding Protein Gephyrin in Alzheimer's DiseaseSemantic proximity Read ↗

Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.Semantic proximity Read ↗

AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive agingSemantic proximity Read ↗

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's DiseaseSemantic proximity Read ↗

A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease.Semantic proximity Read ↗

Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1.Semantic proximity Read ↗

A Neuroligin-1 mutation associated with Alzheimer’s disease produces memory and age-dependent impairments in hippocampal plasticitySemantic proximity Read ↗

miR‐181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer’s diseaseSemantic proximity Read ↗

alpha-Isoform of calcium-calmodulin-dependent protein kinase II and postsynaptic density protein 95 differentially regulate synaptic expression of NR2A- and NR2B-containing N-methyl-d-aspartate receptors in hippocampus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.